Although, further works are required to clarify the roles of O-GlcNAcylation on PI3K/AKT/mTOR regulation under normal physiological context, their interplay is highlighted by their associated dysregulation in several types of cancer, T2D, and cardiovascular and neurodegenerative diseases (Figure 2). The gene discussed is AKT1; the disease is neurodegenerative disease.